Question-and-Answer SessionI thought perhaps we could start with an update on U.S. policy, albeit I'm sure you're sick of talking about it. But on tariffs, we're still awaiting the specifics, but how should we think about Sanofi's potential exposure to U.S. tariffs? Could you give us an indication of the percentage of U.S. sales driven by U.S. manufacturing?Paul HudsonCEO & Director So very happy to be here. Great first question. For tariffs, I think most of us have a placehold of around 15% for 2025. I thi ...